Depreciation of Sunshine Biopharma Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sunshine Biopharma Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Sunshine Biopharma Inc. Depreciation for the quarter ending 30 Sep 2025 was $95,821, a 48% increase year-over-year.
  • Sunshine Biopharma Inc. Depreciation for the twelve months ending 30 Sep 2025 was $221,550.
  • Sunshine Biopharma Inc. annual Depreciation for 2024 was $146,518, a 32% increase from 2023.
  • Sunshine Biopharma Inc. annual Depreciation for 2023 was $110,701, a 436% increase from 2022.
  • Sunshine Biopharma Inc. annual Depreciation for 2022 was $20,641, a 62% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Sunshine Biopharma Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $221,550 $95,821 +$31,194 +48% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $190,356 $72,533 +$21,663 +43% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $168,693 $64,793 +$22,175 +52% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $146,518 $11,597 01 Oct 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q3 2024 $64,627 +$27,417 +74% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $50,870 +$15,993 +46% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $42,618 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q3 2023 $37,210 +$36,421 +4616% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $34,877 +$32,590 +1425% 01 Apr 2023 30 Jun 2023 10-Q/A 20 Aug 2024 2024 Q2
Q4 2022 $20,641 $14,455 +$11,271 +354% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $9,370 $789 -$2,394 -75% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $11,764 $2,287 -$905 -28% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $12,669 $3,110 -$72 -2.3% 01 Jan 2022 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $12,741 $3,184 -$356 -10% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2022 2021 FY
Q3 2021 $13,097 $3,183 -$341 -9.7% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $13,438 $3,192 -$299 -8.6% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $13,737 $3,182 -$329 -9.4% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $14,066 $3,540 01 Oct 2020 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q3 2020 $3,524 +$51 +1.5% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $3,491 +$76 +2.2% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $3,511 +$97 +2.8% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $3,473 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $3,415 01 Apr 2019 30 Jun 2019 10-Q/A 31 Aug 2020 2020 Q2
Q1 2019 $3,414 01 Jan 2019 31 Mar 2019 10-Q 18 May 2020 2020 Q1

Sunshine Biopharma Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $146,518 +$35,817 +32% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 $110,701 +$90,060 +436% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
2022 $20,641 +$7,900 +62% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $12,741 -$1,325 -9.4% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2022 2021 FY
2020 $14,066 01 Jan 2020 31 Dec 2020 10-K 21 Mar 2022 2021 FY
2016 $1,813 +$1,334 +278% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2017 2016 FY
2015 $479 +$479 01 Jan 2015 31 Dec 2015 10-K 17 Apr 2017 2016 FY
2014 $0 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.